VERO Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 16:00):

Stats
Today's Volume	21 981.00
Average Volume	555 107
Market Cap	4.35M
EPS	$0 ( 2024-04-01 )
Next earnings date	( $0 ) 2024-05-13
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.100
ATR14	$0.00900 (1.32%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-18	Ew Healthcare Partners, L.p.	Buy	0	Secured Subordinated Convertible Notes
2023-10-20	Ew Healthcare Partners, L.p.	Buy	502 513	Senior Convertible Preferred Stock
2023-10-04	Madryn Asset Management, Lp	Buy	248 755	Series X Convertible Preferred Stock
2023-10-04	Madryn Asset Management, Lp	Sell	0	Secured Subordinated Convertible Notes
2023-10-04	Madryn Asset Management, Lp	Buy	0	Secured Subordinated Convertible Notes

INSIDER POWER
96.45
Last 85 transactions
Buy: 17 129 331 \| Sell: 297 187

Venus Concept Inc Correlation

10 Most Positive Correlations
EVGN	0.816
ALKT	0.807

10 Most Negative Correlations
CRSA	-0.812

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Venus Concept Inc Financials

Annual	2023
Revenue:	$76.35M
Gross Profit:	$52.17M (68.32 %)
EPS:	$-6.84

FY	2023
Revenue:	$76.35M
Gross Profit:	$52.17M (68.32 %)
EPS:	$-6.84

FY	2022
Revenue:	$99.50M
Gross Profit:	$65.97M (66.30 %)
EPS:	$-9.91

FY	2021
Revenue:	$105.62M
Gross Profit:	$74.09M (70.15 %)
EPS:	$-0.420

Financial Reports:

No articles found.

Venus Concept Inc

Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes aesthetic device platforms, including Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; and Venus Viva, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss, a device for non-invasive lipolysis of the abdomen and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; and ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles. The company is headquartered in Toronto, Canada.